Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
Publication
, Journal Article
Campbell, KR; Mahaffey, KW; Lewis, BE; Weitz, JI; Berkowitz, SD; Ohman, EM; Califf, RM
Published in: J Invasive Cardiol
December 2000
Duke Scholars
Published In
J Invasive Cardiol
ISSN
1042-3931
Publication Date
December 2000
Volume
12 Suppl F
Start / End Page
14F / 149
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombocytopenia
- Safety
- Recombinant Proteins
- Peptide Fragments
- Humans
- Hirudins
- Hirudin Therapy
- Heparin
- Coronary Thrombosis
Citation
APA
Chicago
ICMJE
MLA
NLM
Campbell, K. R., Mahaffey, K. W., Lewis, B. E., Weitz, J. I., Berkowitz, S. D., Ohman, E. M., & Califf, R. M. (2000). Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasive Cardiol, 12 Suppl F, 14F – 149.
Campbell, K. R., K. W. Mahaffey, B. E. Lewis, J. I. Weitz, S. D. Berkowitz, E. M. Ohman, and R. M. Califf. “Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.” J Invasive Cardiol 12 Suppl F (December 2000): 14F – 149.
Campbell KR, Mahaffey KW, Lewis BE, Weitz JI, Berkowitz SD, Ohman EM, et al. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasive Cardiol. 2000 Dec;12 Suppl F:14F – 149.
Campbell, K. R., et al. “Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.” J Invasive Cardiol, vol. 12 Suppl F, Dec. 2000, pp. 14F – 149.
Campbell KR, Mahaffey KW, Lewis BE, Weitz JI, Berkowitz SD, Ohman EM, Califf RM. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasive Cardiol. 2000 Dec;12 Suppl F:14F – 149.
Published In
J Invasive Cardiol
ISSN
1042-3931
Publication Date
December 2000
Volume
12 Suppl F
Start / End Page
14F / 149
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombocytopenia
- Safety
- Recombinant Proteins
- Peptide Fragments
- Humans
- Hirudins
- Hirudin Therapy
- Heparin
- Coronary Thrombosis